L’EFSA publie toutes ses productions scientifiques, y compris ses avis scientifiques, dans l’EFSA Journal. L’Autorité édite également un éventail de publications connexes à l’appui des productions scientifiques. Voir aussi : Definitions of EFSA Scientific Outputs and Supporting Publications.
This statement supplements and updates the GMO Panel guidance document on allergenicity of genetically modified (GM) plants published in 2017. In that guidance document, the GMO Panel considered that additional investigations on in vitro protein digestibi ...
Regulation (EC) No 396/2005 establishes the rules governing the setting and the review of pesticide maximum residue levels (MRLs) at European level. According to Article 12(1) of Regulation (EC) No 396/2005, EFSA shall provide within 12 months from the da ...
Clear guidance on conducting Environmental Risk Assessment (ERA) of nanomaterials is becoming more and more relevant as new applications of nanomaterials in the food and feed chain are developed. Upon request from EFSA, this report compiles and structures ...
The European Commission requested EFSA to provide scientific advice on the translocation potential by Pseudomonas chlororaphis MA342 in plants after seed treatment of cereals and peas and, if applicable, for a revision of the assessment of the risk to hum ...
In this project we set up a human cell‐based DNT in vitro testing strategy that is based on test methods with high readiness and data generated therefrom. The methods underwent afit‐for‐purpose evaluation that considered four key elements: 1. The test sys ...
Following a request from the European Commission, the EFSA assessed the 2018 post‐market environmental monitoring (PMEM) report on the cultivation of Cry1Ab‐expressing maize event MON 810. Like previous years, there was partial compliance with refuge requ ...
This report is the outcome of an EFSA procurement (NP/EFSA/GMO/2018/01) reviewing relevant scientific information on in silico prediction methods for protein toxicity, that could support the food and feed risk assessment. Several proteins are associated w ...
This report describes the tasks performed in the period 6/12/2019 to 16/07/2020under the EFSA contract OC/EFSA/GMO/2018/02, Lot 2 on toxicological studies and animal feeding studies included in applicationsfor market authorisation of genetically modified ...
The Mixed‐lineage leukemia (MLL) gene constitutes a genomic hotspot commonly rearranged/translocated in human acute leukemia (AL). MLL rearrangements (MLL r) represent a common hallmark of both de novo AL and therapy‐related acute myeloid leukemia (t‐AML) ...
This report describes the tasks performed in the period 28/11/2018 to 5/12/2019under the EFSA contract OC/EFSA/GMO/2018/02, Lot 2 on toxicological studies and animal feeding studies included in applicationsfor market authorisation of genetically modified ...